Identification and validation of a novel redox-related lncRNA prognostic signature in lung adenocarcinoma

References

• Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–1075.
   PubMed Web of Science ®Google Scholar
• Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553(7689):446–454.
   PubMed Web of Science ®Google Scholar
• Jiang H, Xu S, Chen C. A ten-gene signature-based risk assessment model predicts the prognosis of lung adenocarcinoma. BMC Cancer. 2020;20(1):782.
   PubMed Web of Science ®Google Scholar
• Li C, Long Q, Zhang D, et al. Identification of a four-gene panel predicting overall survival for lung adenocarcinoma. BMC Cancer. 2020;20(1):1198.
   PubMed Web of Science ®Google Scholar
• D’Autréaux B, Toledano MB. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol. 2007;8(10):813–824.
   PubMed Web of Science ®Google Scholar
• Łuczaj W, Gęgotek A, Skrzydlewska E. Antioxidants and HNE in redox homeostasis. Free radical biology & medicine.. 2017;111: 87–101.
   PubMed Web of Science ®Google Scholar
• Ray PD, Huang BW, Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal. 2012;24(5):981–990.
   PubMed Web of Science ®Google Scholar
• Ursini F, Maiorino M, Forman HJ. Redox homeostasis: the Golden Mean of healthy living. Redox Biol. 2016;8:205–215.
   PubMed Web of Science ®Google Scholar
• Lu GS, Li M, Xu CX, et al. APE1 stimulates EGFR-TKI resistance by activating Akt signaling through a redox-dependent mechanism in lung adenocarcinoma. Cell Death Dis. 2018;9(11):1111.
   PubMedGoogle Scholar
• Ma L, Chen T, Zhang X, et al. The m(6)A reader YTHDC2 inhibits lung adenocarcinoma tumorigenesis by suppressing SLC7A11-dependent antioxidant function. Redox Biol. 2021;38:101801.
   PubMed Web of Science ®Google Scholar
• Mao Q, Wang L, Liang Y, et al. CYP3A5 suppresses metastasis of lung adenocarcinoma through ATOH8/Smad1 axis. Am J Cancer Res. 2020;10(10):3194–3211.
   PubMed Web of Science ®Google Scholar
• Moloney JN, Cotter TG. ROS signalling in the biology of cancer. Semin Cell Dev Biol. 2018;80:50–64.
   PubMed Web of Science ®Google Scholar
• Raza MH, Siraj S, Arshad A, et al. ROS-modulated therapeutic approaches in cancer treatment. J Cancer Res Clin Oncol. 2017;143(9):1789–1809.
   PubMed Web of Science ®Google Scholar
• Sies H, Jones DP. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat Rev Mol Cell Biol. 2020;21(7):363–383.
   PubMed Web of Science ®Google Scholar
• Sosa V, Moliné T, Somoza R, et al. Oxidative stress and cancer: an overview. Ageing Res Rev. 2013;12(1):376–390.
   PubMed Web of Science ®Google Scholar
• Zhang X, Hong R, Chen W, et al. The role of long noncoding RNA in major human disease. Bioorganic chemistry.. 2019;92: 103214.
   PubMed Web of Science ®Google Scholar
• Leisegang MS, Schröder K, Brandes RP. Redox regulation and noncoding RNAs. Antioxid Redox Signal. 2018;29(9):793–812.
   PubMed Web of Science ®Google Scholar
• Cao M, Cai J, Yuan Y, et al. A four-gene signature-derived risk score for glioblastoma: prospects for prognostic and response predictive analyses. Cancer Biol Med. 2019;16(3):595–605.
   PubMed Web of Science ®Google Scholar
• Li Y, Gu J, Xu F, et al. Transcriptomic and functional network features of lung squamous cell carcinoma through integrative analysis of GEO and TCGA data. Sci Rep. 2018;8(1):15834.
   PubMedGoogle Scholar
• Zhang M, Sun L, Ru Y, et al. A risk score system based on DNA methylation levels and a nomogram survival model for lung squamous cell carcinoma. Int J Mol Med. 2020;46(1):252–264.
   PubMed Web of Science ®Google Scholar
• Schober P, Boer C, Schwarte LA. Correlation coefficients: appropriate use and interpretation. Anesth Analg. 2018;126(5):1763–1768.
   PubMed Web of Science ®Google Scholar
• Liu JH, Xu YM, An YJ. 11-lncRNA risk scoring model predicts prognosis of lung squamous cell carcinoma. Eur Rev Med Pharmacol Sci. 2020;24(10):5456–5464.
   PubMed Web of Science ®Google Scholar
• Xiong Y, Yuan L, Xiong J, et al. An outcome model for human bladder cancer: a comprehensive study based on weighted gene co-expression network analysis. J Cell Mol Med. 2020;24(3):2342–2355.
   PubMed Web of Science ®Google Scholar
• Qiu J, Sun M, Wang Y, et al. Identification and validation of an individualized autophagy-clinical prognostic index in gastric cancer patients. Cancer cell international.. 2020;20(1):178.
   PubMed Web of Science ®Google Scholar
• Hu B, Yang XB, Sang XT. Construction of a lipid metabolism-related and immune-associated prognostic signature for hepatocellular carcinoma. Cancer Med. 2020;9(20):7646–7662.
   PubMed Web of Science ®Google Scholar
• Li W, Liu J, Zhao H. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma. Aging (Albany NY). 2020;12(2):1512–1526.
   PubMedGoogle Scholar
• Sun Z, Jing C, Xiao C, et al. Long non-coding RNA profile study identifies an immune-related lncRNA prognostic signature for kidney renal clear cell carcinoma. Front Oncol. 2020;10:1430.
   PubMed Web of Science ®Google Scholar
• Tu Z, Wu L, Wang P, et al. N6-methylandenosine-related lncRNAs are potential biomarkers for predicting the overall survival of lower-grade glioma patients. Front Cell Develop Biol. 2020;8:642.
   PubMed Web of Science ®Google Scholar
• Obuchowski NA, Bullen JA. Receiver operating characteristic (ROC) curves: review of methods with applications in diagnostic medicine. Phys Med Biol. 2018;63(7):07tr1.
   Web of Science ®Google Scholar
• Qi-Dong X, Yang X, Lu JL, et al. Development and validation of a nine-redox-related long noncoding RNA Signature in renal clear cell carcinoma. Oxid Med Cell Longevity. 2020;2020:6634247.
   PubMed Web of Science ®Google Scholar
• Guo D, Wang M, Shen Z, et al. A new immune signature for survival prediction and immune checkpoint molecules in lung adenocarcinoma. J Transl Med. 2020;18(1):123.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang X, Lv X, et al. Development and validation of a seven-gene signature for predicting the prognosis of lung adenocarcinoma. Biol Med Res Int. 2020;2020:1836542.
   PubMed Web of Science ®Google Scholar
• Zhu J, Wang M, Hu D. Development of an autophagy-related gene prognostic signature in lung adenocarcinoma and lung squamous cell carcinoma. PeerJ 2020;8:e8288.
   PubMed Web of Science ®Google Scholar
• Liu GM, Zeng HD, Zhang CY, et al. Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma. Cancer cell international. 2019;19(1):138.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Gou X, Wei Z, et al. Bioinformatics profiling integrating a three immune-related long non-coding RNA signature as a prognostic model for clear cell renal cell carcinoma. Cancer cell international.. 2020;20(1):166.
   PubMed Web of Science ®Google Scholar
• Li T, Fu J, Zeng Z, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48(W1):W509–w14.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang J, Yuan C, et al. Establishment of the prognostic index reflecting tumor immune microenvironment of lung adenocarcinoma based on metabolism-related genes. J Cancer. 2020;11(24):7101–7115.
   PubMed Web of Science ®Google Scholar
• Wang J, Kong PF, Wang HY, et al. Identification of a gene-related risk signature in melanoma patients using bioinformatic profiling. J Oncol. 2020;2020:7526204.
   PubMed Web of Science ®Google Scholar
• Liang JY, Wang DS, Lin HC, et al. A novel ferroptosis-related gene signature for overall survival prediction in patients with hepatocellular carcinoma. Int J Biol Sci. 2020;16(13):2430–2441.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34.
   PubMed Web of Science ®Google Scholar
• Allemani C, Weir HK, Carreira H, et al. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015;385(9972):977–1010.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang DC, Shi L, et al. Genome analyses identify the genetic modification of lung cancer subtypes. Semin Cancer Biol. 2017;42:20–30.
   PubMed Web of Science ®Google Scholar
• Loewen G, Jayawickramarajah J, Zhuo Y, et al. Functions of lncRNA HOTAIR in lung cancer. J Hematol Oncol. 2014;7(1):90.
   PubMed Web of Science ®Google Scholar
• Zhang YX, Yuan J, Gao ZM, et al. LncRNA TUC338 promotes invasion of lung cancer by activating MAPK pathway. Eur Rev Med Pharmacol Sci. 2018;22(2):443–449.
   PubMed Web of Science ®Google Scholar
• Feng C, Zhao Y, Li Y, et al. LncRNA MALAT1 promotes lung cancer proliferation and gefitinib resistance by acting as a miR-200a sponge. Arch Bronconeumol. 2019;55(12):627–633.
   PubMed Web of Science ®Google Scholar
• Galamb O, Barták BK, Kalmár A, et al. Diagnostic and prognostic potential of tissue and circulating long non-coding RNAs in colorectal tumors. World J Gastroenterol. 2019;25(34):5026–5048.
   PubMed Web of Science ®Google Scholar
• Tang D, Zhao L, Peng C, et al. LncRNA CRNDE promotes hepatocellular carcinoma progression by upregulating SIX1 through modulating miR-337-3p. J Cell Biochem. 2019;120(9):16128–16142.
   PubMed Web of Science ®Google Scholar
• Wang G, Pan J, Zhang L, et al. Long non-coding RNA CRNDE sponges miR-384 to promote proliferation and metastasis of pancreatic cancer cells through upregulating IRS1. Cell Prolif. 2017;50(6):6.
   Web of Science ®Google Scholar
• Zhu L, Yang N, Du G, et al. LncRNA CRNDE promotes the epithelial-mesenchymal transition of hepatocellular carcinoma cells via enhancing the Wnt/β-catenin signaling pathway. J Cell Biochem. 2018;120(2):1156–1164.
   PubMed Web of Science ®Google Scholar
• Lin C, Xiang Y, Sheng J, et al. Long non-coding RNA CRNDE promotes malignant progression of hepatocellular carcinoma through the miR-33a-5p/CDK6 axis. J Physiol Biochem. 2020;76(3):469–481.
   PubMed Web of Science ®Google Scholar
• Liu C, Hou J, Shan F, et al. Long non-coding RNA CRNDE promotes colorectal carcinoma cell progression and paclitaxel resistance by regulating miR-126-5p/ATAD2 axis. Onco Targets Ther. 2020;13:4931–4942.
   PubMed Web of Science ®Google Scholar
• Zhang F, Wang H, Yu J, et al. LncRNA CRNDE attenuates chemoresistance in gastric cancer via SRSF6-regulated alternative splicing of PICALM. Mol Cancer. 2021;20(1):6.
   PubMed Web of Science ®Google Scholar
• Wang B, Xu W, Cai Y, et al. CASC15: A tumor-associated long non-coding RNA. Curr Pharm Des. 2021;27(1):127–134.
   Web of Science ®Google Scholar
• Xue MY, Cao HX. Long non-coding RNA CASC15 promotes nasopharyngeal carcinoma cell proliferation and metastasis by downregulating miR-101-3p. Eur Rev Med Pharmacol Sci. 2019;23(20):8897–8904.
   PubMed Web of Science ®Google Scholar
• Zhang YN, Liu B, Jiang T, et al. Long non-coding RNA CASC15 promotes proliferation and induces apoptosis of cervical cancer cells through targeting miR-101-3p. Eur Rev Med Pharmacol Sci. 2020;24(2):611–618.
   PubMed Web of Science ®Google Scholar
• Yu X, Wang ZL, Han CL, et al. LncRNA CASC15 functions as an oncogene by sponging miR-130b-3p in bladder cancer. Eur Rev Med Pharmacol Sci. 2019;23(22):9814–9820.
   PubMed Web of Science ®Google Scholar
• Yu DJ, Zhong M, Wang WL. Long noncoding RNA CASC15 is upregulated in non-small cell lung cancer and facilitates cell proliferation and metastasis via targeting miR-130b-3p. Eur Rev Med Pharmacol Sci. 2019;23(18):7943–7949.
   PubMed Web of Science ®Google Scholar
• Tani H, Numajiri A, Aoki M, et al. Short-lived long noncoding RNAs as surrogate indicators for chemical stress in HepG2 cells and their degradation by nuclear RNases. Sci Rep. 2019;9(1):20299.
   PubMedGoogle Scholar
• Cheng Y, Wang X, Qi P, et al. Tumor microenvironmental competitive endogenous RNA network and immune cells act as robust prognostic predictor of acute myeloid leukemia. Front Oncol. 2021;11:584884.
   PubMed Web of Science ®Google Scholar
• Alvarez-Dominguez C, Calderón-Gonzalez R, Terán-Navarro H, et al. Dendritic cell therapy in melanoma. Ann Transl Med. 2017;5(19):386.
   PubMed Web of Science ®Google Scholar
• Mitchell D, Chintala S, Dey M. Plasmacytoid dendritic cell in immunity and cancer. J Neuroimmunol. 2018;322:63–73.
   PubMed Web of Science ®Google Scholar
• Bing X, Xuelei L, Wanwei D, et al. EGCG maintains Th1/Th2 balance and mitigates ulcerative colitis induced by dextran sulfate sodium through TLR4/MyD88/NF-κB signaling pathway in rats. Can J Gastroenterol Hepatol. 2017;2017:3057268.
   PubMed Web of Science ®Google Scholar
• Lin W, Niu Z, Zhang H, et al. Imbalance of Th1/Th2 and Th17/Treg during the development of uterine cervical cancer. Int J Clin Exp Pathol. 2019;12(9):3604–3612.
   PubMed Web of Science ®Google Scholar
• Keir ME, Butte MJ, Freeman GJ, et al. PD-1 and its ligands in tolerance and immunity. Annual review of immunology.. 2008;26(1):677–704.
   PubMed Web of Science ®Google Scholar
• Leach DR, Krummel MF, Allison JP. Enhancement of antitumor immunity by CTLA-4 blockade. Science. 2017;2017(5256):1–9.
   Google Scholar
• Freud AG, Mundy-Bosse BL, Yu J, et al. The broad spectrum of human natural killer cell diversity. Immunity. 2017;47(5):820–833.
   PubMed Web of Science ®Google Scholar
• Lupo KB, Matosevic S. Natural killer cells as allogeneic effectors in adoptive cancer immunotherapy. Cancers 2019;11:6.
   Web of Science ®Google Scholar
• Crotty S. T follicular helper cell differentiation, function, and roles in disease. Immunity. 2014;41(4):529–542.
   PubMed Web of Science ®Google Scholar
• Gu-Trantien C, Loi S, Garaud S, et al. CD4⁺ follicular helper T cell infiltration predicts breast cancer survival. J Clin Invest. 2013;123(7):2873–2892.
   PubMed Web of Science ®Google Scholar